HEMPGenTech™
High Efficiency Multi-crop Platform (H.E.M.P.™) Genetic Technologies
AUSTRALIAN PLANT BREEDING & COMMERCIAL GENETICS
Industrial Hemp Genetics, Agronomy & Commercialisation
HEMPGenTech develops and commercialises industrial hemp genetics and production systems for growers, seed partners and commercial programs in Australia and international markets.
HEMPGenTech Capabilities
Genetics
Commercial varieties and breeding pipeline.
Agronomy
Genetics × environment × management.
Seed Systems
Multiplication, quality and traceability.
Research & Insights
Peer-reviewed science and applied research.
Commercialisation
Licensing and commercial partnerships.
Global Markets
Australian genetics for international deployment.
Who We Are
Building Stronger Foundations for Emerging Crop Industries
HEMPGenTech was established to bring genetics, plant breeding, agronomy and seed-system discipline into emerging crop industries.
The company operates where science meets commercial reality, connecting variety development, crop management, seed quality, compliance awareness, licensing and market development.
Its current focus includes industrial hemp and sesame, with broader capability in genetic improvement and commercial crop development.
Genetics & Breeding
Australian Industrial Hemp Genetics
HEMPGenTech develops genetics around the interaction between genotype, environment, management and end use. Commercial readiness is treated separately from breeding status, Plant Breeder’s Rights protection, seed multiplication, regulatory availability and market deployment.
- 7 commercial-ready or advanced varieties presented by HGT
- 5 2026 PBR applications submitted to IP Australia
- 12 additional breeding lines maintained in the development pipeline
- 1 integrated genetics, agronomy and seed-system platform
Current Commercial Varieties
HGT1
HGT1 is a dioecious industrial hemp variety suited to selected grain, fibre and dual-purpose production systems, depending on location, sowing window, end use, seed availability and management.
HGT2h
HGT2h is a monoecious, grain-focused industrial hemp variety developed for selected commercial production systems where local conditions, compliance, seed availability and management are suitable.
Advanced Commercial-Ready Variety Cohort
Five additional HGT varieties have progressed to an advanced commercial-ready stage, with Plant Breeder’s Rights applications submitted to IP Australia in 2026. Commercial release and supply remain subject to final HGT approval, seed multiplication, regulatory requirements and market readiness.
- HOMA2hs
- HARMONEY32
- HASTI20
- HARIR57
- HALEH98
Status distinction: PBR application, PBR grant, regulatory registration, seed multiplication and commercial availability remain separate steps.
12-Line Development Pipeline
HEMPGenTech maintains a further 12 breeding lines in its development pipeline. Seven identifiers are currently presented publicly below; five additional internal lines remain under evaluation and will be named publicly only when their identifiers and status are confirmed for release.
- HGT10598
- HGT10533
- HGT040
- HGT020
- HGT057
- HGT029
- HGT103
- Plus five additional internal breeding lines
Agronomy
Genetics Alone Does Not Determine Crop Performance
Industrial hemp management must be designed around genotype × environment × management and the intended end use.
End Use
Define grain, fibre, dual-purpose, seed multiplication, research or another authorised objective before selecting the production pathway.
Variety & Flowering
Match genetic background and flowering response with latitude, season length, photoperiod and the required harvest window.
Sowing & Establishment
Consider soil condition, seed quality, sowing window, depth, equipment, plant density and establishment risk together.
Water & Nutrition
Build irrigation and nutrient decisions around soil evidence, crop stage, end-use target and seasonal conditions.
Crop Protection
Use proactive monitoring and integrated approaches to weed, pest and disease pressure within applicable local rules.
Harvest & Quality
Align crop maturity, machinery, harvest timing, handling and post-harvest requirements with the buyer and product pathway.
Seed Systems
From Genetics to Reliable Planting Seed
Genetic value becomes commercially useful only when it can be reproduced and delivered through a reliable seed system. HEMPGenTech works with HGT Seed Services to connect variety identity, multiplication planning, quality assurance coordination, traceability and delivery readiness.
- Identity. Start with the correct variety, authorised source and intended use.
- Multiplication. Plan generation, isolation, field controls, timing and expected supply needs.
- Quality Assurance. Coordinate appropriate germination, purity, health and other testing.
- Traceability. Maintain lot identity, chain-of-custody information and supporting records.
- Delivery Readiness. Resolve availability, packaging, logistics, permits and planting timing before committing the production program.
Research & Insights
Research, Evidence & Commercial Interpretation
HEMPGenTech publishes peer-reviewed research, technical summaries and evidence-led industry analysis connecting plant genetics and agronomy with practical commercial and policy questions.
Industrial Hemp for PFAS and Heavy-Metal Contaminated Soils
A practical summary of the 2026 peer-reviewed review by Omid Ansari and Luca De Prato, covering evidence, limitations, technology readiness and policy implications.
Hemp Flowering and Photoperiod
A summary of peer-reviewed photoperiod classification work and what it means for variety selection, latitude, sowing windows and commercial fit.
Breeding, Environment and Flowering
Selected HGT conference insights connecting breeding objectives, genotype × environment × management and flowering behaviour.
Compliance
Commercial Genetics Require a Compliant Pathway
Industrial hemp regulation varies between jurisdictions. HEMPGenTech considers licensing, variety status, THC requirements, biosecurity, seed movement, agreements and traceability before commercial deployment.
- Licence and purpose
- Variety and THC rules
- Biosecurity and movement
- Agreements and records
This framework is compliance awareness, not legal or regulatory advice. The grower, importer, exporter or licensee remains responsible for confirming current requirements with the relevant authorities.
Commercialisation
From Genetics to Commercial Deployment
HEMPGenTech works with growers, seed companies, processors, researchers and commercial partners to move appropriate genetics from evaluation into structured commercial programs.
- Define the opportunity. Clarify market, territory, end use, scale and timing.
- Complete diligence. Assess technical fit, regulatory pathway, financial capacity, seed needs and multiplication plan.
- Set the agreement. Document authorised use, territory, volumes, intellectual property, confidentiality, fees, reporting and safeguards.
- Deploy and review. Coordinate supply, traceability and agreed evaluation or commercial milestones.
No trial seed, sample seed, multiplication or commercial supply proceeds outside the required agreements and readiness checks.
Market Development
Australian Genetics for Global Commercial Pathways
Successful crop industries require more than genetics. HEMPGenTech connects genetics, production capability, seed systems, processing requirements and market demand to build commercially realistic pathways.
- Demand and end use
- Production fit
- Processing and logistics
- Commercial network
Commercial Decision Support
Information to Include in a Planting-Seed Enquiry
- Country, state or region and proposed growing location
- Intended end use: grain, fibre, dual purpose, multiplication or research
- Expected planting area, indicative seed quantity and sowing window
- Production system, irrigation status and harvest equipment
- Licence, permit or compliance status relevant to the activity
- Organisation details and person responsible for the program
Common Questions
Industrial Hemp Genetics & Planting Seed FAQs
Which HEMPGenTech varieties are commercially available?
HGT1 and HGT2h are the current commercial industrial hemp varieties presented through HGT. Supply, authorised use and suitability remain subject to seed availability, location, intended purpose, regulatory requirements and an agreed commercial pathway.
Are the five 2026 PBR application varieties available?
Not by virtue of application. HOMA2hs, HARMONEY32, HASTI20, HARIR57 and HALEH98 are presented as a 2026 PBR application cohort. Application, registration, multiplication and commercial release are separate stages.
Can a variety be recommended using location alone?
No. Location must be considered alongside latitude, sowing window, intended end use, production system, management capability and suitable local evidence.
Are the 12 pipeline lines available for sale?
No. They remain under internal evaluation. Any future release depends on evidence, seed multiplication, regulatory requirements, market fit and HGT approval.
Can international organisations enquire?
Yes. International enquiries are assessed case by case, but no seed pathway proceeds until commercial agreements, permits, phytosanitary requirements, compliance checks and seed availability have been addressed.
Where can I read HEMPGenTech research and technical articles?
Peer-reviewed research summaries, technical explanations, commercial implications and policy-focused analysis are published through HEMPGenTech Research & Insights.
Work with HEMPGenTech
Discuss Genetics, Research or a Commercial Opportunity
Work with HEMPGenTech on plant breeding, commercial genetics, research, seed pathways or international deployment.
Contact HEMPGenTech Request the Seed Catalogue
Variety performance can vary with genetics, location, climate, soil, sowing window, management, end use and other production conditions. Descriptive information is general guidance and is not a yield, quality, THC-compliance, profitability or suitability guarantee.
